Overexpression of T lymphoma invasion and metastasis 1 predict renal cell carcinoma metastasis and overall patient survival

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 3, 2011, Pages 393-398

  Zhao, Liang ^a   Liu, Yawei ^a   Sun, Xuegang ^a   He, Minyi ^b   Ding, Yanqing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Metastasis; Poor prognosis; Renal cell carcinoma; T lymphoma invasion and metastasis 1

Indexed keywords

T LYMPHOMA INVASION AND METASTASIS 1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SURVIVAL TIME;

CARCINOMA, RENAL CELL; FEMALE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79954441258     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0895-7     Document Type: Article

References (23)

1. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628-1631 (Pubitemid 29211773)
2. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF et al (2004) Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 10:184-190 (Pubitemid 38114178)
3. Ding Y, Chen B, Wang S, Zhao L, Chen J, Ding Y et al (2009) Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients. Int J Cancer 124:653-658
4. Engers R, Mueller M, Walter A, Collard JG, Willers R, Gabbert HE (2006) Prognostic relevance of Tiam1 protein expression in prostate carcinomas. Br J Cancer 95:1081-1086 (Pubitemid 44606836)
5. Ficarra V, Novara G, Galfano A, Artibani W (2004) Neoplasm staging and organ-confined renal cell carcinoma: a systematic review. Eur Urol 46:559-564 (Pubitemid 39345722)
6. Habets GG, Scholtes EH, Zuydgeest D, van der Kammen RA, Stam JC, Berns A et al (1994) Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77:537-549 (Pubitemid 24153994)
7. Hou M, Tan L, Wang X, Zhu YS (2004) Antisense Tiam1 downregulates the invasiveness of 95D cells in vitro. Acta Biochim Biophys Sin (Shanghai) 36:537-540 (Pubitemid 39434134)
8. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10-30 (Pubitemid 40310185)
9. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P (2001) A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166:63-67 (Pubitemid 32565343)
10. Lam JS, Belldegrun AS, Figlin RA (2004) Advances in immune-based therapies of renal cell carcinoma. Expert Rev Anticancer Ther 4:1081-1096 (Pubitemid 39646563)
11. Lam JS, Leppert JT, Figlin RA, Belldegrun as (2005a) Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep 6:7-18
12. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun as (2005b) Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 173:1853-1862 (Pubitemid 40675199)
13. Landis S, Murray T, Bolden S, Wingo P (1999) Cancer statistics, 1999. CA Cancer J Clin 49:8-31 (Pubitemid 29094959)
14. Lane BR, Li J, Zhou M, Babineau D, Faber P, Novick AC et al (2009) Differential expression in clear cell renal cell carcinoma identified by gene expression profiling. J Urol 181:849-860
15. Liu L, Zhang Q, Zhang Y, Wang S, Ding Y (2006) Lentivirusmediated silencing of Tiam1 gene influences multiple functions of a human colorectal cancer cell line. Neoplasia 8:917-924 (Pubitemid 44706241)
16. Malliri A, van der Kammen RA, Clark K, van der Valk M, Michiels F, Collard JG (2002) Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 417:867-871 (Pubitemid 34670335)
17. Minard ME, Kim LS, Price JE, Gallick GE (2004) The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat 84:21-32 (Pubitemid 38388857)
18. Minard ME, Herynk MH, Collard JG, Gallick GE (2005) The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model. Oncogene 24:2568-2573 (Pubitemid 40593047)
19. Motzer R, Russo P, Nanus D, Berg W (1997) Renal cell carcinoma. Curr Probl Cancer 21:185-232
20. Negrier S, Escudier B, Gomez F, Douillard JY, Ravaud A, Chevreau C et al (2002) Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunotherapie. Ann Oncol 13:1460-1468
21. Patel PH, Chaganti RS, Motzer RJ (2006) Targeted therapy for metastatic renal cell carcinoma. Br J Cancer 94:614-619 (Pubitemid 43361889)
22. Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M et al (2005) A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 173:48-51 (Pubitemid 39627669)
23. Zhao L, Wang H, Li J, Liu Y, Ding Y (2008) Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer. J Proteome Res 7:3994-4003